Abstract
Aims
Heavy proteinuria caused by non-diabetic renal disease (NDRD) is common in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate specific predictors for NDRD in addition to traditional indicators in T2DM.
Methods
A total of 341 patients with T2DM who underwent renal biopsy were retrospectively included. Eligible patients were divided into a nephrotic-range group (n = 194) and a non-nephrotic-range group (n = 147) based on proteinuria level. Risk factors for NDRD were evaluated using logistic regression, and the diagnostic implications of these variables were assessed by subgroup.
Results
Multivariate logistic regression indicated that serum IgG level (OR, 0.762; 95% CI, 0.628–0.924; p = 0.006) was an independent predictor of NDRD in the nephrotic-range group. However, in the non-nephrotic-range group, increased C3 level was an independent risk factor for NDRD (OR, 1.313; 95% CI, 1.028–1.678; p = 0.029). In the nephrotic-range group, the optimal cutoff value of IgG for predicting NDRD was 734.0 mg/dl, with 67.8% sensitivity and 74.8% specificity, and IgG ≤ 734.0 mg/dl was the best predictor of NDRD. In the non-nephrotic-range group, the optimal cutoff value of C3 for predicting NDRD was 122.0 mg/dl with low sensitivity (30.9%) but high specificity (97.8%).
Conclusions
At different levels of proteinuria, reduced IgG and increased C3 levels were independent indicators of NDRD in T2DM. Insights into these factors will help to advance the clinical management of NDRD.
Similar content being viewed by others
References
Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G et al (2017) Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant 32:97–110
Chang TI, Park JT, Kim JK, Kim SJ, Oh HJ, Yoo DE et al (2011) Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract 92:198–204
Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q et al (2017) Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complicat 31:114–121
Lee YH, Kim KP, Kim YG, Moon JY, Jung SW, Park E et al (2017) Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. Medicine 96:e8047
American Diabetes Association (2015) Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 33:97–111
Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2:56–64
Dong Z, Wang Y, Qiu Q, Zhang X, Zhang L, Wu J et al (2016) Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients. Diabetes Res Clin Pract 121:112–118
Erdogmus S, Kiremitci S, Celebi ZK, Akturk S, Duman N, Ates K et al (2017) Non-diabetic kidney disease in type 2 diabetic patients: prevalence, clinical predictors and outcomes. Kidney Blood Press Res 42:886–893
American Diabetes Association (2017) Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes 35:5–26
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB et al (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21:556–563
Weng CH, Hu CC, Yu CC, Lin JL, Yang CW, Hung CC et al (2012) Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus. J Diabetes 4:37–40
Ardawi MS, Nasrat HA, Bahnassy AA (1994) Serum immunoglobulin concentrations in diabetic patients. Diabet Med 11:384–387
Nicoloff G, Blazhev A, Petrova C, Christova P (2004) Circulating immune complexes among diabetic children. Clin Dev Immunol 11:61–66
Kalia K, Sharma S, Mistry K (2004) Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clin Chim Acta 347:169–176
Flyvbjerg A (2017) The role of the complement system in diabetic nephropathy. Nat Rev Nephrol 13:311–318
Zhang J, Wang Y, Zhang R et al (2017) Implication of decreased serum complement 3 in patients with diabetic nephropathy. Acta Diabetol 55:31–39
Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS et al (2013) The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8:1718–1724
Liu S, Guo Q, Han H, Cui P, Liu X, Miao L et al (2016) Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol 48:1691–1698
Dong ZY, Wang YD, Qiu Q, Hou K, Zhang L, Wu J et al (2016) Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics. J Diabetes Investig 7:115–120
Doshi SM, Friedman AN (2017) Diagnosis and Management of Type 2 Diabetic Kidney Disease. Clin J Am Soc Nephrol 12:1366–1373
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant Number 81670662).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The ethics committee of West China Hospital approved this research. The study protocol was in compliance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
Additional information
Managed by Giuseppe Pugliese.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhang, J., Wang, Y., Zhang, R. et al. Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus. Acta Diabetol 56, 873–881 (2019). https://doi.org/10.1007/s00592-019-01339-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-019-01339-0